The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 6,215,238 | 1,736,100 | SH | SOLE | N/A | 1,736,100 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM NEW | 016259202 | 42,186,452 | 13,608,533 | SH | SOLE | N/A | 13,608,533 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 1,085,001 | 459,746 | SH | SOLE | N/A | 459,746 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 1,902,000 | 50,000 | SH | SOLE | N/A | 50,000 | 0 | 0 | ||
| ASLAN PHARMACEUTICALS LTD | SPON ADS NEW | 04522R200 | 1,175,000 | 625,000 | SH | SOLE | N/A | 625,000 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | 2,283,000 | 150,000 | SH | SOLE | N/A | 150,000 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 678,750 | 75,000 | SH | SOLE | N/A | 75,000 | 0 | 0 | ||
| EDESA BIOTECH INC | COM | 27966L108 | 809,981 | 1,281,615 | SH | SOLE | N/A | 1,281,615 | 0 | 0 | ||
| ELEVATION ONCOLOGY INC | COM | 28623U101 | 329,510 | 497,299 | SH | SOLE | N/A | 497,299 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 1,650,420 | 778,500 | SH | SOLE | N/A | 778,500 | 0 | 0 | ||
| GOSSAMER BIO INC | COM | 38341P102 | 2,552,645 | 3,065,136 | SH | SOLE | N/A | 3,065,136 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 7,196,346 | 6,986,744 | SH | SOLE | N/A | 6,986,744 | 0 | 0 | ||
| ICOSAVAX INC | COM | 45114M109 | 1,244,883 | 160,630 | SH | SOLE | N/A | 160,630 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 3,007,365 | 189,500 | SH | SOLE | N/A | 189,500 | 0 | 0 | ||
| INFLARX NV | COM | N44821101 | 596,000 | 200,000 | SH | SOLE | N/A | 200,000 | 0 | 0 | ||
| INHIBRX INC | COM | 45720L107 | 458,750 | 25,000 | SH | SOLE | N/A | 25,000 | 0 | 0 | ||
| INSPIRE MED SYS INC | COM | 457730109 | 3,036,132 | 15,300 | SH | SOLE | N/A | 15,300 | 0 | 0 | ||
| INSPIREMD INC | COM | 45779A846 | 2,956,175 | 904,029 | SH | SOLE | N/A | 904,029 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,137,500 | 250,000 | SH | Call | SOLE | N/A | 250,000 | 0 | 0 | |
| JASPER THERAPEUTICS INC | COM | 471871103 | 1,717,297 | 2,834,036 | SH | OTR | N/A | 0 | 2,834,036 | 0 | ||
| JASPER THERAPEUTICS INC | COM | 471871103 | 5,869,500 | 8,385,000 | SH | SOLE | N/A | 8,385,000 | 0 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 5,211,000 | 75,000 | SH | SOLE | N/A | 75,000 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 3,152,100 | 55,300 | SH | SOLE | N/A | 55,300 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 4,424,139 | 3,596,861 | SH | SOLE | N/A | 3,596,861 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 8,866,350 | 5,185,000 | SH | SOLE | N/A | 5,185,000 | 0 | 0 | ||
| QUIPT HOME MEDICAL CORP | COM | 74880P104 | 509,000 | 100,000 | SH | Call | SOLE | N/A | 100,000 | 0 | 0 | |
| QUIPT HOME MEDICAL CORP | COM | 74880P104 | 5,599,000 | 1,100,000 | SH | SOLE | N/A | 1,100,000 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 528,000 | 400,000 | SH | SOLE | N/A | 400,000 | 0 | 0 | ||
| TELA BIO INC | COM | 872381108 | 5,968,696 | 746,087 | SH | SOLE | N/A | 746,087 | 0 | 0 | ||
| TENET HEALTHCARE CORP | COM NEW | 88033G407 | 1,643,099 | 24,937 | SH | SOLE | N/A | 24,937 | 0 | 0 | ||